Bridgefront Capital, LLC Teva Pharmaceutical Industries LTD Transaction History

Bridgefront Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$10.67 - $14.43 $4,171 - $5,642	-391 Reduced 2.49%	15,292 $215,000
Q4 2023 Feb 14, 2024	BUY	$8.12 - $10.63 $127,345 - $166,710	15,683 New	15,683 $163,000
Q3 2022 Nov 29, 2022	SELL	$6.86 - $11.95 $113,244 - $197,270	-16,508 Reduced 35.36%	30,179 $244,000
Q2 2022 Aug 12, 2022	BUY	$7.38 - $10.4 $344,550 - $485,544	46,687 New	46,687 $351,000
Q4 2021 Feb 10, 2022	SELL	$7.9 - $10.19 $207,714 - $267,925	-26,293 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$8.38 - $10.18 $220,335 - $267,662	26,293 New	26,293 $256,000
Q2 2021 Aug 12, 2021	SELL	$9.9 - $11.56 $256,875 - $299,947	-25,947 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$10.34 - $12.81 $268,291 - $332,381	25,947 New	25,947 $299,000

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.